TENS + Mindfulness Meditation for HIV-Related Pain

"Currently, this clinical trial is seeking 36 HIV-positive individuals between 18 and 89 years old. In order to qualify, applicants must demonstrate the capacity for literacy in English, existing evidence of peripheral neuropathy within their feet; with an accompanying CD4 cell count of no less than 200 cells/mm3 minimum. Furthermore they should have been exposed to ART treatment, possess a viable means of transportation to a study site; report average daily pain scores at 3 or above on the 0-10 numerical scale over the past three months, not undergone any alterations in pain management regimens inside the last 4 weeks; abstained from using either TENS machines"

"This clinical trial's principal outcome to be evaluated over a Week 0 and Week 7 timeline is Pain Interference Change from Baseline at 7 weeks. Other objectives include assessing Adherence to Home-based Treatment (TENS and Mindfulness Meditation groups) which will rely on direct communication with participants, Physical Activity Change from Baseline at 7 weeks which involve the use of an Actigraph activity monitor and International Physical Activity Questionnaire - Short Form, as well as Pain Medication Use Change from Baseline at 7 weeks by way of study-specific questionnaires."

"The minimum age requirement to join this study is 18, while the maximum age limit is 89. There are 108 trials available for those below the legal voting age and 352 specifically targeting seniors over 65 years old."

"The information hosted on clinicaltrials.gov suggests that this trial is still recruiting participants, beginning with the initial posting date of April 22nd 2022, and most recently updated on July 25th 2022."

"Affirmative. Per the clinicaltrials.gov listing, this experiment is actively recruiting participants as of July 25th 2022 after first being posted on April 22nd 2022. Two medical sites are needed to enrol 36 patients in total."